Goldman Sachs
PBH icon

Goldman Sachs’s Prestige Consumer Healthcare PBH Stock Holding History

Goldman Sachs’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,000
Closed -$416K – 5356
2019
Q3 		$416K Buy
+12,000
New +$395K ﹤0.01% 4528
2018
Q4 		– Sell
-40,000
Closed -$1.52M – 5561
2018
Q3 		$1.52M Buy
+40,000
New +$1.51M ﹤0.01% 3774

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs's PBH Position: Q1 2026 in Review

Goldman Sachs reduced its Prestige Consumer Healthcare (PBH) stake by 13% in Q1 2026, selling an estimated $4.48M and leaving 457,618 shares worth $27.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2150.

Goldman Sachs first reported a position in PBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $84.2M in Q2 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Goldman Sachs held 457,618 shares of Prestige Consumer Healthcare worth $27.1M as of Q1 2026.
  • Goldman Sachs sold 69,009 Prestige Consumer Healthcare shares in Q1 2026, an estimated $4.48M.
  • Prestige Consumer Healthcare made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2150 holding.
  • Goldman Sachs first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Prestige Consumer Healthcare position peaked at $84.2M in Q2 2025.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.